Innoviva, Inc. (THRX)
Feb 14, 2024 - THRX was delisted (reason: acquired by Concentra Biosciences)
4.060
0.00 (0.00%)
Inactive · Last trade price on Feb 13, 2024
Theseus Pharmaceuticals Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$11.75
Upside
+189.41%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $23 → $7 | Buy | Maintains | $23 → $7 | +72.41% | Jul 14, 2023 |
| Wedbush | Wedbush | Buy Maintains $24 → $7 | Buy | Maintains | $24 → $7 | +72.41% | Jul 14, 2023 |
| Needham | Needham | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 14, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $22 → $9 | Strong Buy | Maintains | $22 → $9 | +121.67% | Jul 14, 2023 |
| Needham | Needham | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +466.50% | May 26, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +441.87% | May 26, 2023 |
| Needham | Needham | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +466.50% | May 17, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +441.87% | May 12, 2023 |
| Needham | Needham | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +466.50% | May 12, 2023 |
| Stifel | Stifel | Strong Buy Initiates $24 | Strong Buy | Initiates | $24 | +491.13% | Mar 16, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +441.87% | Mar 10, 2023 |
| Needham | Needham | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +466.50% | Mar 10, 2023 |
| Needham | Needham | Strong Buy Initiates $22 | Strong Buy | Initiates | $22 | +441.87% | Dec 14, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $22 | Strong Buy | Initiates | $22 | +441.87% | Jun 30, 2022 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Nov 1, 2021 |
| Wedbush | Wedbush | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Nov 1, 2021 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.